APA (7th ed.) Citation

Kim, M., Kim, S. C., Kim, J., & Kim, B. H. Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus. Korean Diabetes Association.

Chicago Style (17th ed.) Citation

Kim, Mijin, Seung Chan Kim, Jinmi Kim, and Bo Hyun Kim. Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus. Korean Diabetes Association.

MLA (9th ed.) Citation

Kim, Mijin, et al. Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus. Korean Diabetes Association.